Digital wound measurement devices sales will strengthen through 2036, anchored by diabetic ulcer at 32% of the wound type segment in 2026, driven by increasing clinical adoption and expanding procedural volume across hospital systems. The market was valued at USD 1.13 billion in 2025 and is expected to be worth USD 1.97 billion by 2036.